title: Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha.
authors.forename: U
authors.initials: U
authors.lastname: Bacher
authors.forename: A
authors.initials: A
authors.lastname: Hochhaus
authors.forename: U
authors.initials: U
authors.lastname: Berger
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: R
authors.initials: R
authors.lastname: Hehlmann
authors.forename: T
authors.initials: T
authors.lastname: Haferlach
authors.forename: C
authors.initials: C
authors.lastname: Schoch
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002869:Chromosome Aberrations; D002999:Clone Cells / Q000473:pathology; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D000068877:Imatinib Mesylate; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D016898:Interferon-alpha; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate